1h Free Analyst Time
The antibiotics market is forecasted to grow by USD 18.22 billion during 2024-2029, accelerating at a CAGR of 5.9% during the forecast period. The report on the antibiotics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of infectious diseases, government investment regarding antibiotics, and growing awareness of various diseases and their treatment.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The antibiotics market is segmented as below:
By Product
- Broad-spectrum antibiotics
- Narrow-spectrum antibiotics
By Route Of Administration
- Intravenous
- Oral
- Others
By Geographical Landscape
- Asia
- North America
- Europe
- Rest of World (ROW)
The report on the antibiotics market covers the following areas:
- Antibiotics Market sizing
- Antibiotics Market forecast
- Antibiotics Market industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Qualitative Analysis
7 Five Forces Analysis
8 Market Segmentation by Product
9 Market Segmentation by Route of Administration
10 Customer Landscape
11 Geographic Landscape
12 Drivers, Challenges, and Opportunity/Restraints
13 Competitive Landscape
14 Competitive Analysis
15 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global antibiotics market: Abbott Laboratories, AbbVie Inc., Armata Pharmaceuticals Inc., Aspen Pharmacare Holdings Ltd., Astellas Pharma Inc., Aurobindo Pharma Ltd., Bayer AG, F. Hoffmann La Roche Ltd., Flynn Pharma Ltd., GlaxoSmithKline Plc, Incepta Pharmaceuticals Ltd., Johnson and Johnson Services Inc., Lupin Ltd., Mayne Pharma Group Ltd., Melinta Therapeutics LLC, Merck KGaA, Pfizer Inc., Sanofi SA, Takeda Pharmaceutical Co. Ltd., and Teva Pharmaceutical Industries Ltd..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is strategic alliances and mergers and acquisitions."
According to the report, one of the major drivers for this market is the rising prevalence of infectious diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- AbbVie Inc.
- Armata Pharmaceuticals Inc.
- Aspen Pharmacare Holdings Ltd.
- Astellas Pharma Inc.
- Aurobindo Pharma Ltd.
- Bayer AG
- F. Hoffmann La Roche Ltd.
- Flynn Pharma Ltd.
- GlaxoSmithKline Plc
- Incepta Pharmaceuticals Ltd.
- Johnson and Johnson Services Inc.
- Lupin Ltd.
- Mayne Pharma Group Ltd.
- Melinta Therapeutics LLC
- Merck KGaA
- Pfizer Inc.
- Sanofi SA
- Takeda Pharmaceutical Co. Ltd.
- Teva Pharmaceutical Industries Ltd.
